1. To assess the impact of accepting expanded criteria donor kidneys. 
2. To determine the benefit of using kidneys from donors with diabetes mellitus. 
3. To evaluate the outcomes of kidneys from deceased donors with acute kidney injury. 

Marcelo Cantarovich, MD (Buenos Aires, Argentina), nephrology/transplant fellow (Paris, France), FRCPC (Canada), is Professor of Medicine, and Associate Director (Multi-Organ Transplant Program) at McGill University (Montreal, Canada). He currently serves as TTS President. His research focuses on multi-organ transplantation, immunopharmacology and renal protection strategies. He has published over 140 manuscripts in peer-reviewed journals. He is past President of the Canadian Society of Transplantation (CST); chaired/co-chaired the TTS and the CST Education Committee, CST Fellows’ Symposium and CST Congress, the AST Clinical Trials Symposium, TTS Post-Graduate Course (2010, 2016, 2018, 2020). He is the Chair of the TTS 2022 Congress in Buenos Aires. His primary focus is continuing education for young and established TTS members and increase global access to transplantation.

Dr. Jean Tchervenkov is a full professor of surgery at McGill University and a multi-organ transplant surgeon. He began his career in 1990 and established the Liver Transplantation Programme at McGill. From 1990-2004 he was the director of the programme. From 2004-2007 he was the director of the Multi-organ transplant programme at McGill University. His areas of research have been the establishment of a successful protocol to prevent reinfection with hepatitis B after liver transplantation, the use of the slope of the tumor marker alpha-fetoprotein pre-liver transplantation to predict cancer recurrence and the use of expanded criteria donors in renal and liver transplantation. Currently, his research focus is looking at the role of Tregs and Th17 lymphocytes in renal reperfusion injury, acute T cell rejection, and antibody mediated rejection (ABMR) and chronic ABMR.